Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald E Mager

Showing results (81-90 of 163) with videos related to

Pageof 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Effect of repetitive administration of Doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution in a rat brain tumor modelRobert D Arnold, Donald E Mager, Jeanine E Slack, et al.
Journal of Pharmaceutical Sciences|October 23, 2023
Target Reserve and Turnover Parameters Determine Rightward Shift of Enalaprilat Potency From its Binding Affinity to the Angiotensin Converting EnzymeVan Anh Nguyen, Li Zhang, Leonid Kagan, et al.
Biopharmaceutics & Drug Disposition|October 24, 2013
Population-based meta-analysis of furosemide pharmacokineticsScott A Van Wart, Susan E Shoaf, Suresh Mallikaarjun, et al.
Biopharmaceutics & Drug Disposition|June 25, 2013
Population pharmacokinetics of tolvaptan in healthy subjects and patients with hyponatremia secondary to congestive heart failure or hepatic cirrhosisScott A Van Wart, Susan E Shoaf, Suresh Mallikaarjun, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 28, 2003
Receptor-mediated pharmacokinetics and pharmacodynamics of interferon-beta1a in monkeysDonald E Mager, Berend Neuteboom, Constantinos Efthymiopoulos, et al.
Biopharmaceutics & Drug Disposition|October 15, 2013
Population-based meta-analysis of hydrochlorothiazide pharmacokineticsScott A Van Wart, Susan E Shoaf, Suresh Mallikaarjun, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 16, 2025
Multispecies minimal physiologically based pharmacokinetic-pharmacodynamic model of antisense oligonucleotides for central nervous system disordersDevam A Desai, Mfonabasi E Ette, Dhaval K Shah, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 14, 2026
Hybrid Systems Modeling of Donor T-Cell Responses and Graft-Versus-Host-Disease After Posttransplantation Cyclophosphamide AdministrationHsuan-Hao Fan, Jeannine S McCune, Christopher G Kanakry, et al.
Science Translational Medicine|March 24, 2012
Merging systems biology with pharmacodynamicsRavi Iyengar, Shan Zhao, Seung-Wook Chung, et al.
Journal of Pharmaceutical Sciences|April 27, 2013
Allometry of factor VIII and informed scaling of next-generation therapeutic proteinsMatthew P Kosloski, Dipak S Pisal, Donald E Mager, et al.
Pageof 17

Showing results (81-90 of 163) with videos related to

Sort By:
Pageof 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Effect of repetitive administration of Doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution in a rat brain tumor modelRobert D Arnold, Donald E Mager, Jeanine E Slack, et al.
Journal of Pharmaceutical Sciences|October 23, 2023
Target Reserve and Turnover Parameters Determine Rightward Shift of Enalaprilat Potency From its Binding Affinity to the Angiotensin Converting EnzymeVan Anh Nguyen, Li Zhang, Leonid Kagan, et al.
Biopharmaceutics & Drug Disposition|October 24, 2013
Population-based meta-analysis of furosemide pharmacokineticsScott A Van Wart, Susan E Shoaf, Suresh Mallikaarjun, et al.
Biopharmaceutics & Drug Disposition|June 25, 2013
Population pharmacokinetics of tolvaptan in healthy subjects and patients with hyponatremia secondary to congestive heart failure or hepatic cirrhosisScott A Van Wart, Susan E Shoaf, Suresh Mallikaarjun, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 28, 2003
Receptor-mediated pharmacokinetics and pharmacodynamics of interferon-beta1a in monkeysDonald E Mager, Berend Neuteboom, Constantinos Efthymiopoulos, et al.
Biopharmaceutics & Drug Disposition|October 15, 2013
Population-based meta-analysis of hydrochlorothiazide pharmacokineticsScott A Van Wart, Susan E Shoaf, Suresh Mallikaarjun, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 16, 2025
Multispecies minimal physiologically based pharmacokinetic-pharmacodynamic model of antisense oligonucleotides for central nervous system disordersDevam A Desai, Mfonabasi E Ette, Dhaval K Shah, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 14, 2026
Hybrid Systems Modeling of Donor T-Cell Responses and Graft-Versus-Host-Disease After Posttransplantation Cyclophosphamide AdministrationHsuan-Hao Fan, Jeannine S McCune, Christopher G Kanakry, et al.
Science Translational Medicine|March 24, 2012
Merging systems biology with pharmacodynamicsRavi Iyengar, Shan Zhao, Seung-Wook Chung, et al.
Journal of Pharmaceutical Sciences|April 27, 2013
Allometry of factor VIII and informed scaling of next-generation therapeutic proteinsMatthew P Kosloski, Dipak S Pisal, Donald E Mager, et al.
Pageof 17